Clinical Trial Update: Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sildenafil citrate for the management of asymmetrical intrauterine growth restriction is listed, with status currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction

Drugs mentioned

• Sildenafil citrate (Sildenafil citrate)

Snippet

Sponsor: Assiut University | Conditions: Intrauterine Growth Restriction | Phase 2 | Status: UNKNOWN